Consistently, we found that FXR deletion almost completely diminished the Zbtb18-induced beneficial effects on lipid deposition and glucose metabolism dysfunction in vivo and in vitro, coupled with a lack of effects on insulin resistance. Here, ZBTB18 is linked to Insulin resistance.